Zhejiang Huakang Pharmaceutical Co., Ltd. (SHA:605077)

China · Delayed Price · Currency is CNY

11.53

+0.22 (1.95%)

Sep 30, 2026, 3:00 PM CST

Market Cap	3.45B -38.1%
Revenue (ttm)	4.80B +44.9%
Net Income	108.56M -58.9%
EPS	0.36 -51.4%
Shares Out	299.08M
PE Ratio	32.37
Forward PE	n/a
Dividend	0.50 (4.34%)
Ex-Dividend Date	Jun 17, 2026

Volume	6,893,351
Open	11.39
Previous Close	11.31
Day's Range	11.32 - 11.55
52-Week Range	9.97 - 19.48
Beta	0.65
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2026

About SHA:605077

Zhejiang Huakang Pharmaceutical Co., Ltd. engages in the research, production, and sale of polyols and starch sugar worldwide. The company offers polyols products such as xylitol, is a polyol that occurs naturally regular sugar raise blood sugar levels; sorbitol, is produced by the catalytic hydrogenation of D-glucose and is available as a free-flowing crystalline powder, and as aqueous solutions; maltitol a bulk sweetener produced from naturally occurring compounds in corn; erythritol, is produced by the enzymatic hydrolysis of starch into glu... [Read more]

Industry Chemicals

Sector Materials

Founded 2001

Employees 2,248

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 605077

Full Company Profile

Financial Performance

In 2025, SHA:605077's revenue was 4.19 billion, an increase of 49.15% compared to the previous year's 2.81 billion. Earnings were 200.30 million, a decrease of -25.40%.

Financial Statements